Viewing Study NCT01593527


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-03-01 @ 12:34 PM
Study NCT ID: NCT01593527
Status: WITHDRAWN
Last Update Posted: 2017-04-20
First Post: 2012-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module